Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF)

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Cystic Fibrosis
Interventions
DRUG

P-1037

P-1037 is a novel ENaC inhibitor

DRUG

Hypertonic Saline

4.2% saline solution

DRUG

Saline

0.17% saline solution

Trial Locations (33)

11042

Long Island Jewish Medical Center, New Hyde Park

12208

Albany Medical College, Albany

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

21287

Johns Hopkins University, Baltimore

22908

University of Virginia Childrens, Charlottesville

27517

University of North Carolina, Chapel Hill

28277

Clinical Research of Charlotte, Charlotte

29425

Medical University of South Carolina, Charleston

29621

Anderson Pharmaceutical Research, Anderson

32610

Univ of Florida Dept of Medicine, Gainesville

32803

Central Florida Pulmonary Group, PA, Orlando

33136

University of Miami Adult CF Center, Miami

33606

New Lung Associates, Tampa

37232

Vanderbilt University Medical Center, Nashville

43606

Toledo Hospital, Toledo

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

48201

Wayne State University/Harper University Hospital, Detroit

53792

University of Wisconsin UW Hospital, Madison

60025

Chicago Cystic Fibrosis Institute, Glenview

63110

Washington University, St Louis

66160

University of Kansas Medical Center, Kansas City

70112

Tulane University Health Sciences Center, New Orleans

73112

Santiago Reyes, Oklahoma City

75390

UT Southwestern Medical Center, Dallas

75708

Univ of Texas Health Science Center, Tyler

78212

Alamo Clinical Research Associates, San Antonio

78723

Austin Children's Chest Associates, Austin

90027

Children's Hospital of Los Angeles, Los Angeles

04102

Maine Medical Center, Portland

01655

UMass Memorial medical Center, Worcester

03756

Dartmouth Hitchcock Medical Center, Lebanon

08901

Rutgets-Robert Wood Johnson Medical School, New Brunswick

08876

Pediatric Pulmonology/Cystic Fibrosis, Somerville

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

lead

Parion Sciences

INDUSTRY